BioMarin Pharma (BMRN) Tops Q1 EPS by 46c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $55.95 +0.74%
EPS Growth %: -34.0%
Financial Fact:
Interest income: 1.63M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -34.0%
Financial Fact:
Interest income: 1.63M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of $0.63, $0.46 better than the analyst estimate of $0.17. Revenue for the quarter came in at $519 million versus the consensus estimate of $507.52 million.
GUIDANCE:
BioMarin Pharma sees FY2022 revenue of $2.05-2.15 billion.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Oxford Industries (OXM) Tops Q1 EPS by 12c; Offers Outlook
- The Lovesac Company (LOVE) Tops Q1 EPS by 29c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
